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~ Isolation and identification of "difficult" pathogens from 
CF airways: molecular analysis results 
R Cocchi, N. Ravenni, G. Taccetti, S. Campana. Cystic Fibrosis Center, Department 
of Paediatrics, University of Florence, Florence, Italy 
Introduction; An increasing number of Cystic Fibrosis (CF) pathogens results 
difficult to identify: unusual bacteria nd novel species recovered from respiratory 
samples represent an additional challenge. Conventional tools for isolation and 
identification sometimes failed to give results, so that the prevalence and potential 
pathogenic role of these species remain unclear. Ribosomal DNA sequencing has 
greatly facilitated the identification of these bacteria, so that we investigate the 
utility of 16S rRNA gene (16S rDNA) sequencing. 
Methods; We examined a total of 25 strains, grown on Burkholderia cepacia 
Selective Agar (BCSA) and Mac Conkey Agar (MCK) which were unable to 
be identified by traditional identification biochemical tests. DNA was extracted 
and, according to published protocols, we amplified a 1000 nucleotides portion of 
16S rDNA. These nucleotide sequences were then determined and compared with 
GeneBank database. 
Results and conclusions; 3 out of 25 strains are grown on BCSA (12%): 2 
isolates belong to the Chryseobacterium genus and 1 to the Burkholderia cepacia 
complex (Bcc). 22 out of 25 strains are grown on MCK: 5 isolates identified as 
Bcc members (22.7%) failed to grow on Bcc specific medium (BCSA) so that 
they would be undetected; 3 as S. marcescens (13.7%); 2 as P aeruginosa (9%); 
4 as S. malthophilia (18.3%), 4 as A. xylosoxidans (18.3%), 1 as P agglomerans 
(4.5%), 1 as Acinetobacter s T (4.5%), 1 as Chryseobacterium s T (4.5%) and 1 as 
Enterobacter s T (4.5%). This kind of approach allows to identify both emerging 
pathogens and unusual isolates and improves our undestanding about he complexity 
of bacterial community within CF lung. 
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~ Characteristics of a new transmissible multiresistant 
Pseudomonas aeruginosa strain with a unique genotype 
R Meyer 1 , A.-C. Petersson 2. 1 CF-unit, Pediatric linic, 2Clinical Microbiology 
and Immunology, University Hospital, Lund, Sweden 
Background; Epidemiological- and pulsed field gel electrophoresis (PFGE) data 
strongly indicates transmission of a multiresistant Pseudomonas eruginosa (Pa) 
strain at a winter camp for CF-children in Sweden 2005. PFGE analysis showed 
a unique pattern assigned J-strain. This pattern was identical for strains from 
other patients attending the same camp but living in different parts of Sweden 
(unpublished ata). Segregation and hygiene routines were clear cut and respected. 
The transmission route is unknown. 
Aim; The aim of the study was to characterize this new transmissible Pa J strain by 
sequence analysis and susceptibility testing and compare it to known transmissible 
Pa genotypes. 
Methods: Species identity was verified by sequence analysis of 16S rDNA. 
Molecular characterization was performed by multilocus equence typing (MLST) 
according to Curran et al (J Clin Microbiol 2004, 42:5644 49). Antibiotic 
susceptibility testing was performed using the disc diffusion method (Oxoid) and 
E-tests (AB Biodisk). 
Results: MLST was performed in two steps, where the first step included analysis 
of three loci in order to screen for known epidemic strains. The analysis show that 
the Pa J strain differs from all known epidemic strains described so far. 
The antibiogram showed susceptibility for colistin but resistance to all other 
tested antibiotics (meropenem, aztreonam, piperacillin/tazobactam, gentamicin, to- 
bramycin, ceftazidime, ciprofloxacin). 
Conclusion; A new multiresistant transmissible strain of Pa has been identified. 
MLST indicates a unique genotype not related to previously described epidemic 
strains. 
• Molecular epidemiology of the longitudinal course of the 
Pseudomonas aeruginosa infection in Cystic Fibrosis 
N. Cramer 1 , L. Wiehlmann 1 , G. Wagner 2, B. Tiimmler 1 . 1Klinische 
Forschergruppe OE 6711, Medizinische Hochschule Hannover; 2Clondiag 
Chip Technologies', .lena, Germany 
More than 350 sequential Pseudomonas eruginosa isolates which were retrieved 
from 36 cystic fibrosis (CF) patients ince the onset of colonization over an up 
to 20-year period were genotyped by a high-throughput DNA chip that allows the 
identification of the P aeruginosa genotype by SNP-typing and the repertoire of 
the accessory genome. In order to gain insight into the adaptation o fP  aeruginosa 
to the CF lung habitat, the following issues were addressed: are there changes in 
the core genome or the gene islands; how long does a clone persist in the lung; are 
there stable co-colonisations and is there any correlation between the clone and the 
clinical status of the colonised patient? 
Results. Fourty-two percent of the analysed patients had only one clone during 
the whole observation time, whereas the other 58% were co-colonized with more 
than one clone at at least one point of time. The SNP-pattern was more conserved 
than that of the gene islands implying that the evolutionary clock of the core 
genome runs at a slower speed than that of the islands. By year 6 only 50% of the 
initial clones were still detected in the patients' airways. Most co-colonisations were 
observed between the first four years. Radiations (microevolution) occurred more 
often in alive patients than in patients, who deceased uring the study. Therefore, 
we propose that bacterial genome remodelling leads to a better adaptation between 
the host and the opportunistic pathogen. Furthermore, we suggest hat radiation 
decreases the host immune response and leads to a milder course of lung disease 
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• Survey of Pseudomonas aeruginosa (PA) genotypes in a regional 
paediatric shared care CF service 
H. Wyatt 1, M. Graver 2, G. Ruiz 1 , J. Wade 2, T. Pitt 3, J. Price 1 . 1 CF Unit, 2Dept. 
of Microbiology, King ~' College Hospital, 3 Centre for Infections, HPA, London, 
UK 
Aim; To determine the prevalence of clusters of PA with the same genotype and 
thereby whether the shared care system promotes effective infection control. 
Methods; Any patient attending one of the nine clinics in the King's College 
Hospital Regional Paediatric CF service was included. These outreach clinics were 
held at the patients' local hospital and contained between 7 and 20 children. 
Segregation by culture results was practised in all clinics. PA samples from 
cultures collected over a 17 month period were genotyped by Pulsed Field Gel 
Electrophoresis atthe regional reference laboratory. 
Results; 150 patients (75M), median age(range) 9.35y(0.45 18.25). 21 (14%) 
patients had never cultured PA. 94 (63%) of the others had at least one PA positive 
culture during the collection period and PA from 69 of these patients was sent for 
genotyping (typing unsuccessful in 4); the rest of the patients either had only one 
PA positive culture, which was not saved inadvertently (23), or no positive culture 
(30) in that time. 
Most (77%) PA genotypes were unique. Seven different PA genotypes were seen in 
15 unrelated patients. Three patients had Liverpool Epidemic Strain (LES); two of 
these attended the same clinic and also mixed socially. Six other pairs of children 
shared a PA with same the genotype, five of the pairs were geographically quite 
separate. The sixth pair attended the same shared care clinic. 
Conclusion; There was little evidence of cross infection of PA across the region. 
The cohorting of patients by this system of shared care clinics may reduce the risk 
of transmission of respiratory tract organisms. Segregation of patients within their 
own clinic remains essential. 
